Editorial Board for section 'Drug Targeting and Design'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: ADME (drug absorption, distribution, metabolism and elimination); subcellular drug delivery; oral drug delivery; peptide drugs; 3D culture models; organoids; predictive pharmacokinetics; drug-drug interactions; proteomics
2. Centre de Recherche des Cordeliers, INSERM, Université de Paris Cité, Sorbonne Université, From Physiopathology of Ocular Diseases to Clinical Development, 75006 Paris, France
3. Cochin Hospital, AP-HP, Assistance Publique Hôpitaux de Paris, 24 rue du Faubourg Saint Jacques, 75014 Paris, France
Interests: neuroprotection; diabetic retinopathy; retinal ischemia; glia; drug development
Special Issues, Collections and Topics in MDPI journals
Interests: natural products; drug delivery; liposomes; lipid nanocarriers; micro and nanoemulsions; nanoparticles; solubility; stability; bioefficacy; oral, brain and skin delivery; PAMPA test
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; drug discovery; small molecules; antitumor agents; kinase inhibitors; synthetic lethality
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; nanomedicine; nanotechnology; biophysics; fluorescence; pharmaceutics; micro/nanoencapsulation
Interests: tumor microenvironment; spatial heterogeneity; tumor immunology; therapeutic resistance; pancreatic cancer; liver cancer
Interests: medicinal chemistry; GPCR; enzyme; neuroprotective agents; cystic fibrosis; cancer; molecular modeling; virtual screening; homology modeling; repositioning
Special Issues, Collections and Topics in MDPI journals
Interests: cancer diagnostics; 2D and 3D models for cancer studies; mechanisms-of-action of novel drugs; immortalization of cell lines from patients; proteomics; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: lung cancer; NSCLC; SCLC; mesothelioma; immunotherapy; target therapy; new drugs; tumor biomarkers
Interests: target discovery and validation; drug discovery and development; assay design and optimization; chemogenomics
Special Issues, Collections and Topics in MDPI journals
Interests: adjuvants; antigen delivery; mucosal delivery; mucosal vaccines; preclinical validation
Interests: drug delivery; drug targeting; polymer; lipid based nanoparticles; age-related formulations; nanoparticles production by microfluidics; tumor targeting
Special Issues, Collections and Topics in MDPI journals
Interests: novel Ru-based nanosystems for cancer therapy
Special Issues, Collections and Topics in MDPI journals
Interests: antimicrobial peptides; pathogenic bacteria; breast cancer; cancer-targeting agents; cancer diagnostics
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; nanomedicine; targeted therapy; cancer; CNS diseases
Interests: pain; topical administration; adverse effects; analgesics; treatment
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacy; clinical pharmacology; cancer biology oncology; glucuronosy; transferase 5ugt
Special Issues, Collections and Topics in MDPI journals
2. Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
Interests: biomaterials; drug delivery; cancer immunotherapy; nanomedicine; cancer nanotechnology; molecular pharmaceutics
Special Issues, Collections and Topics in MDPI journals
Interests: pyrazolo[3,4-d]pyrimidines; kinase inhibitors; anticancer agents; small molecules
Special Issues, Collections and Topics in MDPI journals
Interests: polymeric drug delivery systems; nanomedicines; reversal of tumor; conventional formulations; regulation of nanomedicines
Interests: anesthesia; cancer; mitochondrial dynamics; pharmacoproteomics
Special Issues, Collections and Topics in MDPI journals
Interests: imunology; immunopharmacology; oncology; clinical oncology; drug targeting
Interests: drug design; serotonin receptors ligands; sigma receptors ligands; heme oxygenase-1 inhibitors; structure-activity relationships; organic synthesis of bioactive compounds
Interests: rational drug design; chemical genetics; medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; medicinal chemistry; molecular modelling; antibacterial agents; anticancer agents
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; pharmaceutical technology; brain delivery; cancer delivery
Special Issues, Collections and Topics in MDPI journals
Interests: drug discovery; structure-property relationships; in vitro drug metabolism; lipidomics; high resolution mass spectrometry
2. Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
Interests: radiolabeled probe; nuclear medicine; molecular imaging
Interests: chemical biology; medicinal bioinorganic chemistry; anticancer drug; anti-Alzheimer's disease drug; drug design; mechanism of action; platinum-based anticancer drug
Interests: radiolabeling strategies; radiotracer development; development of contrast agents for PCCT
Special Issues, Collections and Topics in MDPI journals